Univest
Univest
  • Markets

Artemis Medicare Services Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

  • August 7, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Artemis Medicare Services Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

CMP Rs 276.2. Target 2027: Rs 275 (+0%). Target 2028: Rs 330 (+19%). Target 2030: Rs 475 (+72%).

Artemis Medicare Services at Rs 276.2 is a diversified company whose share price target of Rs 275 for 2027 represents approximately 0 percent upside from the current market price. The Artemis Medicare Services share price target rises to Rs 330 by 2028 and Rs 475 by 2030, implying a 4-year upside of approximately 72 percent from August 2026 levels. Assuming approximately20% annual earnings growth off a FY26 base EPS of ₹6.5 and a fair multiple of approximately35x (moderating to approximately16% growth long-term), the stock’s valuation trend poin.

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Artemis Medicare Services share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Artemis Medicare Services Company Overview
  • Why Is the Artemis Medicare Services Share Price Target Set at Rs 275 for 2027
    • Core Business Revenue Growth and Market Position
    • Margin Improvement and Operational Efficiency
    • Balance Sheet Quality and Cash Flow Generation
    • Management Track Record and Strategic Execution
    • India’s Economy Growth Creates Sector-Wide Tailwind for Artemis Medicare Services
  • Artemis Medicare Services Share Price Targets 2027, 2028 and 2030
    • Artemis Medicare Services Share Price Target 2027: Rs 275
    • Artemis Medicare Services Share Price Target 2028: Rs 330
    • Artemis Medicare Services Share Price Target 2030: Rs 475
  • Bull Case and Bear Case for Artemis Medicare Services Share Price Target 2030
    • Bull Case: Rs 608
    • Bear Case: Rs 356
  • Key Risks to the Artemis Medicare Services Share Price Target
    • Earnings Growth Deceleration
    • Macro and Sector Headwinds
    • Competition and Market Share Pressure
    • Premium Valuation Risk
  • How to Invest in Artemis Medicare Services
  • Conclusion
  • Frequently Asked Questions on Artemis Medicare Services Share Price Target 2027 2028 and 2030
    • What is the Artemis Medicare Services share price target for 2027?
    • What is the Artemis Medicare Services share price target for 2030?
    • What is the Artemis Medicare Services share price target for 2028?
    • Is Artemis Medicare Services a good long-term investment?
    • What are the key risks to the Artemis Medicare Services share price target?
    • What is the bull case for Artemis Medicare Services share price by 2030?
    • What is Artemis Medicare Services’s current market cap?
    • How can I invest in Artemis Medicare Services?

Artemis Medicare Services Company Overview

Metric Details
NSE Ticker ARTEMISMED
Sector Diversified
CMP (06 Aug 2026) Rs 276.2
Market Cap Rs 4376 Cr
FY26 EPS Rs 6.5 (16% annual growth)
Artemis Medicare Services Share Price Target 2027 Rs 275 (+0%)
Artemis Medicare Services Share Price Target 2028 Rs 330 (+19%)
Artemis Medicare Services Share Price Target 2030 Rs 475 (+72%)
Bull Case 2030 Rs 608
Bear Case 2030 Rs 356

What most investors miss: Promoted by Apollo Tyres Group; promoter holding down 10.5% over 3 years

Assuming approximately20% annual earnings growth off a FY26 base EPS of ₹6. 5 and a fair multiple of approximately35x (moderating to approximately16% growth long-term), the stock’s valuation trend points to the figures above. The share price target of Rs 275 for 2027 and Rs 475 for 2030 reflect this earnings trajectory.

Why Is the Artemis Medicare Services Share Price Target Set at Rs 275 for 2027

Core Business Revenue Growth and Market Position

This is the primary driver of the Artemis Medicare Services share price target for 2027 and 2030. Assuming approximately20% annual earnings growth off a FY26 base EPS of ₹6.5 and a fair multiple of approximately35x (moderating to approximately16% growth long-term), the stock’s. Investors tracking this metric quarterly will have the earliest signal of whether the Artemis Medicare Services share price target timeline is on track.

Margin Improvement and Operational Efficiency

The Artemis Medicare Services share price target of Rs 275 for 2027, rising to Rs 475 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Artemis Medicare Services share price target thesis.

Balance Sheet Quality and Cash Flow Generation

This structural factor underpins the long-term Artemis Medicare Services share price target of Rs 475 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Management Track Record and Strategic Execution

For the Artemis Medicare Services share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 330 target in 2028 when earnings quality is most clearly visible.

India’s Economy Growth Creates Sector-Wide Tailwind for Artemis Medicare Services

India’s long-term economic growth trajectory creates a secular tailwind for Artemis Medicare Services’s business that amplifies the company-specific earnings compounding embedded in the Artemis Medicare Services share price target 2030 of Rs 475 (+72% from CMP Rs 276.2).

Artemis Medicare Services Share Price Targets 2027, 2028 and 2030

Artemis Medicare Services Share Price Target 2027: Rs 275

The Artemis Medicare Services share price target 2027 is Rs 275, representing approximately 0 percent upside from CMP Rs 276.2. Assuming approximately20% annual earnings growth off a FY26 base EPS of ₹6.5 and a fair multiple of approximately35x (moderating to approximately16% growth long-term), the stock’s valuation trend poin. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Artemis Medicare Services share price target.

Artemis Medicare Services Share Price Target 2028: Rs 330

The Artemis Medicare Services share price target 2028 is Rs 330, implying approximately 19 percent upside from CMP. By FY29, Artemis Medicare Services should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Artemis Medicare Services share price target thesis typically triggers institutional re-rating toward the Rs 330 level.

Artemis Medicare Services Share Price Target 2030: Rs 475

The Artemis Medicare Services share price target 2030 is Rs 475, implying approximately 72 percent upside from CMP and a 4-year CAGR of approximately 15 percent. By FY31, Artemis Medicare Services should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for Artemis Medicare Services Share Price Target 2030

Bull Case: Rs 608

The bull case Artemis Medicare Services share price target of Rs 608 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 356

The bear case Artemis Medicare Services share price target of Rs 356 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario Target 2030 Return
Bull Case Rs 608 +120%
Base Case Rs 475 +72%
Bear Case Rs 356 +29%

Key Risks to the Artemis Medicare Services Share Price Target

Earnings Growth Deceleration

Any slowdown in Artemis Medicare Services’s core earnings growth below the projected rate would trigger a PE de-rating and delay the Artemis Medicare Services share price target timeline.

Macro and Sector Headwinds

Global or Indian economic slowdown, regulatory changes, or commodity price cycles could negatively impact Artemis Medicare Services’s revenues and the Artemis Medicare Services share price target.

Competition and Market Share Pressure

Competitive intensity from existing players or new entrants could force Artemis Medicare Services to reduce prices or increase spending, compressing the Artemis Medicare Services share price target margins.

Premium Valuation Risk

If the current PE multiple is not supported by sustained earnings delivery, a de-rating could set back the Artemis Medicare Services share price target timeline materially.

How to Invest in Artemis Medicare Services

Use the Univest Screener to track Artemis Medicare Services’s quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker ARTEMISMED. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Artemis Medicare Services share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The Artemis Medicare Services share price target of Rs 275 for 2027, Rs 330 for 2028, and Rs 475 for 2030 reflects analyst consensus earnings compounding in the diversified sector. The 4-year upside of approximately 72 percent from CMP Rs 276.2 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Download the Univest iOS App or Univest Android App to track Artemis Medicare Services share price live and get daily stock recommendations.

Frequently Asked Questions on Artemis Medicare Services Share Price Target 2027 2028 and 2030

What is the Artemis Medicare Services share price target for 2027?

Ans. The Artemis Medicare Services share price target for 2027 is Rs 275, representing approximately 0 percent upside from CMP Rs 276.2 as of August 2026. Please verify all data at NSE India before investing.

What is the Artemis Medicare Services share price target for 2030?

Ans. The Artemis Medicare Services share price target for 2030 is Rs 475, implying approximately 72 percent upside from CMP Rs 276.2. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the Artemis Medicare Services share price target for 2028?

Ans. The Artemis Medicare Services share price target for 2028 is Rs 330, implying approximately 19 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is Artemis Medicare Services a good long-term investment?

Ans. Artemis Medicare Services has a defined analyst projection for earnings compounding through FY31 in the diversified sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the Artemis Medicare Services share price target?

Ans. Key risks include sector-specific headwinds such as earnings growth deceleration, macro and sector headwinds, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for Artemis Medicare Services share price by 2030?

Ans. The bull case Artemis Medicare Services share price target for 2030 is Rs 608, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is Artemis Medicare Services’s current market cap?

Ans. Artemis Medicare Services has a market cap of approximately Rs 4376 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in Artemis Medicare Services?

Ans. You can buy Artemis Medicare Services shares through any SEBI-registered broker by searching for NSE ticker ARTEMISMED. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.



News
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply